Introduction {#s0005}
============

Considering all central nervous system (CNS) and brain tumors, meningiomas are the most frequently diagnosed intracranial masses and comprise more than one third of all entities [@bb0005]. According to the WHO classification and grading system of CNS tumors, there are three groups of meningiomas: benign (grade I), atypical (grade II), and anaplastic (grade III) [@bb0010]. Among these different groups, low-grade meningiomas (WHO I), with approximately 80%-90% of all cases, by far constitute the largest proportion [@bb0015], [@bb0020]. They are associated with lower recurrence rates after surgery and better overall prognosis compared to high-grade meningiomas (WHO grade II and III) [@bb0025], [@bb0030].

Gross total resection including the infiltrated dura mater is still the standard treatment of diagnosed meningiomas [@bb0035]. However, depending on the location and extension of the tumor, surgery may be associated with considerable surgical complication rates and thus with higher overall mortality especially in elderly patients [@bb0040]. This and the fact that a significant fraction of all meningiomas remains asymptomatic and is discovered incidentally highlight the requirement of reliable imaging modalities, particularly in terms of predicting tumor grade, growth kinetics, and other prognostic biomarkers to prevent unnecessary surgery.

Up to now, magnetic resonance imaging (MRI) and the visual evaluation of macroscopic tumor characteristics assessed *via* routinely used MRI sequences, more specifically T1-weighted, T2-weighted, and gadolinium-enhanced sequences, are still the gold standard of the pretherapeutic diagnostics [@bb0035]. Although morphological key features like tumor-brain interface, capsular enhancement, or heterogeneous tumor enhancement were shown to be of potential value in differentiation between low-grade and high-grade meningiomas [@bb0045], [@bb0050], traditional MRI diagnostic remains a subjective and consecutively observer-dependent method requiring experience and expertise of the observing radiologist. One possible approach to decrease intra- and interobserver variability in this regard is to simply quantify mean signal intensities using region of interest (ROI) analysis. However, concerning meningiomas, this method unveiled neither significant differences between low- and high-grade meningiomas nor a correlation with Ki-67 expression representing proliferative activity [@bb0055].

An increasingly performed and certainly promising approach of processing and quantifying MRI data in an objective manner is histogram analysis (HA) of whole lesion volumes [@bb0060]. A variety of recent investigations exemplarily showed the potential of HA to predict tumor biology using elaborate functional imaging techniques like diffusion-weighted imaging, which notoriously reflects underlying tissue microarchitecture [@bb0060], [@bb0065], [@bb0070], [@bb0075], [@bb0080], [@bb0085], [@bb0090]. Furthermore, the value of HA in the neuro-oncological workflow to distinguish morphologically similar mass lesions has been demonstrated [@bb0095]. However, investigations using histogram analysis of conventional MR imaging data are sparse [@bb0100].

Therefore, the aim of this study was to evaluate whether whole tumor histogram profiling of preoperative contrast-enhanced T1-weighted images has the capability to 1) reflect the prognostically relevant Ki-67 expression, representing the cell proliferation kinetics of the corresponding lesion, and 2) differentiate between low-grade and high-grade meningiomas.

Patients, Procedures, and Methods {#s0010}
=================================

Ethics Approval {#s0015}
---------------

The study was approved by the ethics committee of the medical council of Baden-Württemberg (Ethik-Kommission Landesärztekammer Baden-Württemberg, F-2017-047).

Patients Collective {#s0020}
-------------------

The institutional radiological information system was searched for patients with the diagnosis meningioma. Fifty-six patients were identified between 01/2012 and 08/2017, all of which had surgery with at least partial removal of the tumor in our hospital and subsequent neuropathological workup. Only patients who received pretreatment MRI scans with sufficient quality of the T1-weighted spin echo sequences after intravenous application of contrast medium were included. MRI examinations of patients indicating hemorrhage or significant calcifications were excluded since these conditions severely influence quantification of the signal intensities. Therefore, only 44 patients (37 females, 7 males; ranging from 40 to 87 years with a mean age of 61.4 years) were included in our retrospective analysis.

MRI Specifics {#s0025}
-------------

For all patients, MRI of the brain was performed using a 1.5-T device (MAGNETOM Aera, MAGNETOM Symphony and MAGNETOM Sonata; Tx/Rx CP head coil, Siemens, Erlangen, Germany). The imaging protocol included the following sequences:•Axial T1-weighted (T1w) spin echo (SE) sequences (TR/TE: 453/17, flip angle: 90°, slice thickness: 5 mm, acquisition matrix: 320×179, field of view: 230×187 mm) prior and post intravenous application of contrast medium (Gadobutrol, Gadovist, Bayer Schering Pharma, Leverkusen, Germany)

All images were available in digital form and analyzed by two experienced radiologists (G.A.G., S.S.) without knowledge of the histopathological diagnosis on a PACS workstation (Impax EE R20 XII).

Histogram Profiling of T1-Weighted Postcontrast Images {#s0030}
------------------------------------------------------

T1-weighted postcontrast images were exported from our institutional archive in DICOM format *via* the aforementioned AGFA PACS. Using a custom-made DICOM image analysis tool (programmed using Matlab, The Mathworks, Natick, MA), whole lesion histogram profiling was performed as follows: T1-weighted postcontrast images of each patient were loaded into a graphical user interface, and ROIs of the whole contrast enhancing lesion were manually drawn. The histogram profile was consecutively calculated, providing the following set of parameters: SImean, SImin, SImax, SIp10, SIp25, SIp75, SIp90, SImodus, SImedian, skewness, kurtosis, and entropy.

Neuropathology {#s0035}
--------------

All tumor specimens were used for neurohistological confirmation of the diagnosis. A 5-μm section of each tumor was stained by H&E, and two further sections were employed for Ki-67 immunohistochemistry to determine the proliferation rate of each tumor, as previously reported [@bb0105]. The histopathological images were digitalized with a Jenalumar microscope carrying a 4.2 digital camera (Zeiss, Jena, Germany). Thereupon, Ki-67 index was quantified using the ImageJ particles tool as described previously [@bb0060].

Statistical Analysis {#s0040}
--------------------

Statistical analysis including graphics creation was performed using SPSS 24.0 (SPSS Inc., Chicago, IL). In a first step, SI data and histopathological information were investigated using descriptive statistics. In a second step, data were tested for homogeneity of variance (homoscedasticity) using Levene's test. *t* test was performed to compare evaluated, homoscedastic parameters of SI histogram profiling between low-grade and high-grade meningiomas. Mann-Whitney *U* test was performed to compare parameters exhibiting heteroscedastic data between low-grade and high-grade meningiomas. Finally, correlation analysis for homoscedastic parameters was performed using Pearson correlation coefficient. In case of heteroscedastic data, Spearman-Rho rank-order correlation was calculated. *P* values \< .05 were taken to indicate statistical significance in all instances.

Results {#s0045}
=======

[Figure 1](#f0005){ref-type="fig"} shows examples of cranial MRI from patients with low-grade (upper case) and high-grade meningiomas (lower case) with the corresponding whole tumor SI histogram and the Ki-67 immunohistochemical staining.Figure 1Representative MRI sections, the corresponding whole tumor SI histogram, H&E staining, and Ki-67 immunohistochemistry from a low-grade (A-D) and a high-grade meningioma (E-H).The first image of each case gives the T1-weighted section post gadolinium application, showing the meningioma in its maximum diameter; the second image displays the whole tumor SI histogram (*x*-axis: SI values in incremental order, *y*-axis: number of voxels).H&E staining and Ki-67 immunohistochemistry are displayed on the right. For the first case (low-grade meningioma), a proliferation index of 5% was calculated. In the second case (high-grade meningioma), proliferation index was 10%.Figure 1

The results of the descriptive analysis of SI data and histopathological information are summarized in [Table 1](#t0005){ref-type="table"}. Levene's test revealed homoscedasticity of the data for SImean, SImin, SImax, SIp10, SIp25, SIp75, SIp90, SImodus, SImedian, entropy, kurtosis, skewness, and tumor volume. Heteroscedasticity was determined for Ki-67.Table 1Tumor Volume and SI Histogram Parameters of All Investigated MeningiomasTable 1ParametersMean ± Standard DeviationMinimumMaximumLesion volume × 10^3^ mm^3^25.82 ± 21.083.208.13SI~mean~655.32 ± 181.55393.001270.00SI~min~191.66 ± 105.801.00449.00SI~max~1002.52 ± 263.12608.001746.00P10 SI524.81 ± 173.67237.001021.00P25 SI605.40 ± 186.86349.001206.00P75 SI720.66 ± 200.21433.001444.00P90 SI757.30 ± 208.53453.001513.00Median SI671.55 ± 191.51404.001362.00Mode SI664.56 ± 216.70255.001415.00Kurtosis6.52 ± 3.321.3715.34Skewness−1.00 ± 0.74−2.740.46Entropy4.29 ± 0.572.975.53

Consequently, (unpaired) *t* test was used to compare SImean, SImin, SImax, SIp10, SIp25, SIp75, SIp90, SImodus, SImedian, entropy, kurtosis, skewness, and tumor volume between low-grade and high-grade meningiomas. Mann-Whitney *U* test was used to compare Ki-67 between low-grade and high-grade meningiomas. In brief, neither the investigated signal intensity histogram parameters nor the tumor volume revealed significant differences between low-grade and high-grade meningiomas. As expected, high-grade meningiomas showed statistically significant higher Ki-67 expression than low-grade meningiomas, representing the proliferative activity of the tumor. The complete results of the comparative statistical analysis are given in [Table 2](#t0010){ref-type="table"}.Table 2Comparison of SI Histogram Profiles, Ki-67 Index, and Lesion Volume between Low-Grade and High-Grade MeningiomasTable 2ParametersLow-Grade\
Mean ± SDHigh-Grade\
Mean ± SD*P* ValuesSI~mean~680.61 ± 168.89574.04 ± 183.54.496SI~min~197.26 ± 102.33154.30 ± 103.00.890SI~max~1023.00 ± 264.31915.20 ± 229.86.716P10 SI548.63 ± 154.35436.64 ± 177.98.500P25 SI632.54 ± 174.04514.78 ± 187.81.430P75 SI747.08 ± 191.60641.70 ± 205.89.527P90 SI783.70 ± 201.85677.47 ± 214.88.536Median SI695.78 ± 183.09598.70 ± 192.38.589Mode SI692.06 ± 210.51576.50 ± 214.96.521Kurtosis6.90 ± 3.416.01 ± 3.66.686Skewness−1.15 ± 0.72−0.72 ± 0.74.151Entropy4.22 ± 0.584.38 ± 0.53.221Ki-674.59 ± 2.5611.80 ± 8.77**\<.001**Lesion volume × 10^3^ mm^3^22.20 ± 16.8132.12 ± 28.58.117

Pearson's correlation coefficient was used to investigate the association between SImean, SImin, SImax, SIp10, SIp25, SIp75, SIp90, SImodus, SImedian, entropy, kurtosis, skewness, and tumor volume. Spearman-Rho rank-order correlation was calculated to investigate the association between SImean, SImin, SImax, SIp10, SIp25, SIp75, SIp90, SImodus, SImedian, entropy, kurtosis, skewness, tumor volume, and Ki-67. Significant correlations (*P* \< .05) were identified between Ki-67 and the two SI histogram parameters skewness and entropy, between entropy and tumor volume, as well as between tumor volume and Ki-67. The complete results of the correlative analysis are summarized in [Table 3](#t0015){ref-type="table"}. [Figure 2](#f0010){ref-type="fig"}*C* shows a scatter plot graphically demonstrating the association of entropy and tumor volume, the set of parameters with the strongest correlation (*r* = 0.732, *P* \< .001).Figure 2Scatter plots showing significant correlation between entropy and Ki-67 expression (A), between skewness and Ki-67 expression (B), and between entropy and tumor volume (C).Figure 2Table 3Correlations between SI Histogram Profile Parameters and Ki-67 and Lesion Volume of All Investigated Meningiomas.Table 3SI Histogram Profile Parameters/Lesion VolumeKi-67Lesion VolumeSI~mean~*r* = −0.057\
*P* = .697*r* = 0.085\
*P* = .556SI~min~*r* = −0.036\
*P* = .805*r* = −0.069\
*P* = .634SI~max~*r* = 0.126\
*P* = .389*r* = 0.267\
*P* = .061P10 SI*r* = −0.064\
*P* = .663*r* = 0.068\
*P* = .638P25 SI*r* = −0.082\
*P* = .575*r* = 0.045\
*P* = .759P75 SI*r* = −0.012\
*P* = .936*r* = 0.096\
*P* = .506P90 SI*r* = 0.002\
*P* = .988*r* = 0.096\
*P* = .505Median SI*r* = −0.024\
*P* = .872*r* = 0.082\
*P* = .572Mode SI*r* = −0.017\
*P* = .908*r* = 0.023\
*P* = .872Kurtosis*r* = −0.073\
*P* = .617*r* = 0.031\
*P* = .830Skewness***r* = 0.297**\
***P* = .038***r* = 0.261\
*P* = .068Entropy***r* = 0.314**\
***P* = .028*r* = 0.732**\
***P* \< .001**Lesion volume***r* = 0.473**\
***P* = .001--**[^1]

Discussion {#s0050}
==========

To the best of our knowledge, this is the first study using a whole-tumor histogram approach to investigate T1-weighted gadolinium-enhanced images in meningiomas.

As excellently summarized by Just and coworkers [@bb0070], histogram analysis provides first-order characteristics which describe the manifestation of a specific feature (in our case, signal intensity) by means of simple descriptive statistics like mean, mode, median, minimum, maximum, and percentiles. Furthermore, second-order characteristics---skewness, kurtosis, and entropy---are also provided. These three dimensions reflect the shape of the signal intensity distribution of the investigated volume and thus provide more elaborate insight into the imaging architecture of an investigated lesion.

As expected, in accordance with previously published data, first-order characteristics of SI of postcontrast T1w MRI were not significantly different in our collective when comparing low-grade with high-grade meningiomas [@bb0055]. However, in contrast to all first-order characteristics, two items of second-order characteristics---entropy and skewness---showed an interesting trend towards distinction, albeit the conventional significance level of *P*=.05 was not achieved. We thereupon hypothesize that differences in second-order characteristics between both groups are certainly existent but subtle, and therefore, greater cohorts are necessary to achieve statistical significance.

This assumption is corroborated by the fact that both skewness and entropy showed significant correlations with expression of Ki-67. The nuclear protein is only expressed by actively proliferating cells and has been demonstrated to be a valuable molecular marker for differentiation between low-grade and high-grade meningiomas and estimation of tumor recurrence risk [@bb0110].

Also, entropy correlated significantly with tumor volume, which understandably is closely linked to tumor aggressiveness and was reported to be a strong predictor of high-grade meningiomas in cross-sectional imaging features [@bb0115].

The strongest imaging-histology correlation in our collective was found between Ki-67 labeling index and entropy. The entropy of an image is a parameter describing the degree of randomness of the respective dimension within this image. It has been used as an imaging biomarker for tumor heterogeneity in previous reports on different tumor entities [@bb0080], [@bb0120], [@bb0125]. Concerning histogram profiling of diffusion-weighted MRI, a more functional technique investigating the mobility of protons in biological tissues, entropy was shown to be capable of differentiating between different tumor grades [@bb0130] and further on to be significantly correlated with Ki-67 labeling index [@bb0090].

However, most previous studies examined histograms of diffusion-weighted imaging, but data for SI histograms of conventional MRI are sparse.

Only one recent study by Meyer and coworkers employed histogram analysis on conventional MRI of primary central nervous system lymphomas and reported significant imaging-histology correlations [@bb0100]. These results are in line with our presented data and encourage our hypothesis that second-order histogram parameters of simple MRI imaging data reflect certain histopathological changes and thus provide additional valuable insight into tumor biology.

More specifically, considering the results of the aforementioned studies, we take our findings as a strong indication that second-order characteristics like skewness and entropy of simple SI histograms can reflect histopathological changes, which accompany higher proliferation rates (Ki-67) and increased tumor volumes, and thus are subsidiary imaging biomarkers for tumor grade and overall prognosis, complementing the role of advanced diffusion-weighted imaging techniques.

There are some limitations of our study. First of all, it is a single-center retrospective design and based on a relative small cohort of patients. Another limitation is that only data from 1.5-T MRI systems were available, and further investigations using a 3.0-T MRI device with a higher spatial resolution would be beneficial for validation of the present results. Moreover, only postcontrast T1-weigthed images were analyzed, and additional studies investigating histograms of other morphological MRI sequences, like T2-weighted images, should be undertaken.

Conclusions {#s0055}
===========

Pretherapeutic histogram analysis of common morphological MRI sequences like postcontrast T1-weighted images has the potential of predicting growth kinetics and therefore estimating prognosis in the case of meningiomas.
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[^1]: Significant results are given in bold.
